摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(41S,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carbaldehyde | 53412-07-0

中文名称
——
中文别名
——
英文名称
(41S,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carbaldehyde
英文别名
(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carbaldehyde
(4<sup>1</sup>S,13aS)-13a-ethyl-2,3,4<sup>1</sup>,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carbaldehyde化学式
CAS
53412-07-0
化学式
C20H22N2O
mdl
——
分子量
306.407
InChiKey
NDZVZZBOSPYFTQ-UXHICEINSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    400.9±45.0 °C(predicted)
  • 密度:
    1.30±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    25.2
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (41S,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carbaldehyde 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 反应 0.5h, 以75%的产率得到eburnamenine-14-ylmethanol
    参考文献:
    名称:
    Asymmetric Total Synthesis of (+)-Apovincamine and a Formal Synthesis of (+)-Vincamine. Demonstration of a Practical “Asymmetric Linkage” between Aromatic Carboxylic Acids and Chiral Acyclic Substrates
    摘要:
    Asymmetric syntheses of (+)-apovincamine (1a) and (+)-vincamine (2) are described. Construction of the pentacyclic diene lactam 14, a pivotal intermediate for synthesis of the cis-fused vincane-type alkaloids, began by Birch reduction-alkylation of the chiral benzamide 3 to give the 6-ethyl-1-methoxy-4-methyl-1,4-cyclohexadiene 4. Conversion of 4 to 2,5-cyclohexadienone 5 (92% overall yield from 3) and HPLC analysis of 5 demonstrated the diastereomeric purity resulting from the Birch reduction-alkylation to be >100:1. Dienone 5 was converted to butyrolactone 9 (47% overall yield from 3), and 9 was coupled with tryptamine (10) to give the amide 11a. Amido keto aldehyde 13 was obtained from 11a, and acid-catalyzed tricyclization and subsequent base-induced elimination of MeOH provided the desired cis-fused pentacyclic diene lactam 14. Examination of the two-step process 13 --> 14 revealed a novel base-induced epimerization at C(21) which served to interconvert 14 and 17, possibly by the involvement of a homoenolate. Diene lactam 14 was converted to (+)-apovincaminal 20a, an intermediate in the synthesis of (+)-apovincamine (1a) reported by Winterfeldt and co-workers. A new procedure for conversion of 20a to 1a involves conversion of 20a to the acetal 20b and treatment of 20b with NBS/AIBN in CCl4. The conversion of 1a to vincamine (2) has been reported by Oppolzer and co-workers.
    DOI:
    10.1021/jo961603p
  • 作为产物:
    参考文献:
    名称:
    DIAZA-BENZOFLUORANTHRENE COMPOUNDS
    摘要:
    揭示了一系列二氮杂苯并芴类化合物。本发明特别涉及一种由式(I)表示的化合物,其药学上可接受的盐或互变异构体。
    公开号:
    US20180016270A1
点击查看最新优质反应信息

文献信息

  • Diaza-benzofluoranthrene compounds
    申请人:HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARMACEUTICAL FACTORY
    公开号:US10017507B2
    公开(公告)日:2018-07-10
    Disclosed are a series of diaza-benzofluoranthrene compounds. The present invention particularly relates to a compound represented by formula (I), pharmaceutically acceptable salts or tautomers thereof.
    本发明公开了一系列重氮苯并菲化合物。本发明尤其涉及由式(I)代表的化合物、其药学上可接受的盐或同系物。
  • [EN] DIAZA-BENZOFLUORANTHRENE COMPOUNDS<br/>[FR] COMPOSÉS DIAZA-BENZOFLUORANTHRÈNE<br/>[ZH] 二氮杂-苯并荧蒽类化合物
    申请人:MEDSHINE DISCOVERY INC
    公开号:WO2016124129A1
    公开(公告)日:2016-08-11
    本发明公开了一系列二氮杂-苯并荧蒽类化合物,具体涉及式(Ⅰ)所示化合物、其药学上可接受的盐或其互变异构体。
  • DIAZA-BENZOFLUORANTHRENE COMPOUNDS
    申请人:HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARMACEUTICAL FACTORY
    公开号:US20180016270A1
    公开(公告)日:2018-01-18
    Disclosed are a series of diaza-benzofluoranthrene compounds. The present invention particularly relates to a compound represented by formula (I), pharmaceutically acceptable salts or tautomers thereof.
    揭示了一系列二氮杂苯并芴类化合物。本发明特别涉及一种由式(I)表示的化合物,其药学上可接受的盐或互变异构体。
  • Asymmetric Total Synthesis of (+)-Apovincamine and a Formal Synthesis of (+)-Vincamine. Demonstration of a Practical “Asymmetric Linkage” between Aromatic Carboxylic Acids and Chiral Acyclic Substrates
    作者:Arthur G. Schultz、William P. Malachowski、You Pan
    DOI:10.1021/jo961603p
    日期:1997.3.1
    Asymmetric syntheses of (+)-apovincamine (1a) and (+)-vincamine (2) are described. Construction of the pentacyclic diene lactam 14, a pivotal intermediate for synthesis of the cis-fused vincane-type alkaloids, began by Birch reduction-alkylation of the chiral benzamide 3 to give the 6-ethyl-1-methoxy-4-methyl-1,4-cyclohexadiene 4. Conversion of 4 to 2,5-cyclohexadienone 5 (92% overall yield from 3) and HPLC analysis of 5 demonstrated the diastereomeric purity resulting from the Birch reduction-alkylation to be >100:1. Dienone 5 was converted to butyrolactone 9 (47% overall yield from 3), and 9 was coupled with tryptamine (10) to give the amide 11a. Amido keto aldehyde 13 was obtained from 11a, and acid-catalyzed tricyclization and subsequent base-induced elimination of MeOH provided the desired cis-fused pentacyclic diene lactam 14. Examination of the two-step process 13 --> 14 revealed a novel base-induced epimerization at C(21) which served to interconvert 14 and 17, possibly by the involvement of a homoenolate. Diene lactam 14 was converted to (+)-apovincaminal 20a, an intermediate in the synthesis of (+)-apovincamine (1a) reported by Winterfeldt and co-workers. A new procedure for conversion of 20a to 1a involves conversion of 20a to the acetal 20b and treatment of 20b with NBS/AIBN in CCl4. The conversion of 1a to vincamine (2) has been reported by Oppolzer and co-workers.
查看更多

同类化合物

阿扑长春胺 长春醇 长春酸胺 长春西汀杂质N 长春西汀杂质L 长春西汀杂质K 长春西汀杂质J 长春西汀杂质I 长春西汀杂质27 长春西汀杂质1 长春西汀杂质 A 长春西汀 长春胺杂质 长春胺杂质 长春胺乙酯 长春胺 长春泊林 长春布宁 长春倍酯 长春乙酯羧酸 象牙酮宁 溴长春胺 富马酸溴长春胺 埃那胺 7-氨基-4-羟基-3-(苯偶氮基)萘-2-磺基酸 14,15-二氢阿扑长春胺乙酯 13alpha-乙基-2,3,5,6,13a,13b-六氢-1H-吲哚并(3,2,1-去)吡啶并(3,2,1-ij)(1,5)-萘啶-12-羧酸甲氧基甲基酯 (3alpha,16alpha)-6-羟基-象牙洪达木烯宁-14(15H)-酮 (3alpha,14beta,16alpha)-14,15-二氢-14-羟基埃那美宁-14-甲醇 (+)-(14beta)-二氢长春西丁 (+/-)-vincaminine (3α)-Eburnamenine-14-carbonyl chloride hydrochloride (-)-3S,16R-14-benzoyloxymethyl-eburnamenine apovincamine acetylsalicylate (+)-vinpocetine-9,11-disulfonic acid (3-methoxypropyl)diamide 14-(aminomethyl)-vincane O-((eburnamenine-14-yl)methyl)(4-methoxyphenyl)carbamothioate O-((eburnamenine-14-yl)methyl)(4-chlorophenyl)carbamothioate O-((eburnamenine-14-yl)methyl)(morpholine-4-carbonyl)(phenyl)carbamothioate (+)-14-carboxy-eburnamenine(3,16)-10-sulfonamide vinpocetine hydrochloride (+)-14-(2-chloro)carboethoxy-eburnamenine(3,16)-10-sulfonic acid (3-methoxypropyl)amide (+)-14-carbopropyloxy-eburnamenine(3,16)-10-sulfonic acid (3-methoxypropyl)amide (+)-apovincamine-10-sulfonic acid (3-methoxypropyl)amide 4-oxide 6-hydroxy-py-tetrahydroapovincamine chloride 10-nitro-6-oxovincamine (41S,13aS)-13a-ethyl-N,N-dimethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5] naphthyridine-12-carboxamide N-(((41S,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-12-yl)methyl)isobutyramide vincamine acetylsalicylate 6-hydroxy-py-tetrahydro-16-deoxyepivincamine chloride